-
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES TrialGG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al. -
Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment The EARLY Randomized TrialG Lemesle, M Laine, M Pankert et al.
-
Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic ShockKatz SD, Smilowitz NR, Hochman JS.
-
Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarctionKwong RY, Sattar H, Wu H et al.
-
Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesSchüpke S, Neumann FJ, ISAR-REACT 5 Trial Investigators.
-
Refractory Angina: From Pathophysiology to New Therapeutic Nonpharmacological TechnologiesG Gallone, L Baldetti, G Tzanis et al.
-
Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel studyB Schnorbus, A Daiber, T Gori et al.
-
Intensive Care Utilization in Stable Patients With ST-Segment Elevation Myocardial Infarction Treated With Rapid ReperfusionJS Shavadia, AY Chen, AC Fanaroff et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
